Fildena Extra Power-150 Fortune Health Care — Research Summary
Fildena Extra Power-150 is a pharmaceutical research compound containing sildenafil citrate, a potent and selective phosphodiesterase type 5 (PDE-5) enzyme inhibitor. Originally developed by Pfizer, sildenafil citrate demonstrates significant biological activity in vascular research models, particularly those investigating cyclic guanosine monophosphate (cGMP) signalling pathways. Fortune Health Care’s formulation provides researchers at Stroid UK Shop with a standardised research tool for examining PDE-5 inhibition mechanisms in controlled laboratory environments.
Research Applications
Sildenafil citrate serves as a valuable research compound for investigating vascular smooth muscle relaxation pathways and nitric oxide-mediated signalling mechanisms. Researchers studying cardiovascular physiology examine how PDE-5 inhibition affects intracellular cGMP concentrations in arterial tissue models. The compound’s selectivity for PDE-5 over other phosphodiesterase isoforms makes it particularly useful for researchers investigating specific enzyme pathways. Studies within our pharmaceutical research collection often utilise sildenafil citrate alongside other vascular modulators to examine complex cardiovascular mechanisms. Additionally, researchers investigating pulmonary vascular resistance and smooth muscle contractility find this compound essential for their experimental protocols. The compound’s well-documented mechanism of action provides researchers with predictable results when studying PDE-5 enzyme kinetics and substrate interactions in tissue culture systems.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Sildenafil Citrate |
| Concentration | 150mg per unit |
| CAS Number | 171599-83-0 |
| Molecular Weight | 666.70 g/mol |
| Solubility | Water soluble (citrate salt) |
| Storage | Room temperature, dry environment |
Researchers frequently combine sildenafil citrate studies with investigations into selective androgen receptor modulators when examining comprehensive hormonal pathway interactions, while others incorporate findings with peptide research to understand complex vascular signalling cascades.
Compliance Information
Fildena Extra Power-150 is supplied strictly for in-vitro laboratory research purposes only. This compound is not intended for human consumption, therapeutic use, or any application outside controlled research environments. Researchers must ensure proper laboratory protocols, waste disposal procedures, and institutional oversight when conducting studies with this pharmaceutical research compound. All experimental work should comply with relevant laboratory safety guidelines and institutional review requirements.
